When IVF fails at the very last hurdle, it can feel like a cruel blow.

You had your transfer. You waited out the two weeks before beta testing. And then you got a negative.

It can feel like it will never work.

Even after transferring the best-graded embryo. Even after PGT testing. Implantation failure is still a possibility — and when it happens, it raises a question your clinic may not have fully answered.

What can I do differently next time?

It begins with understanding that implantation is a phase in its own right — one that deserves the same attention as egg quality and sperm health.

Fertility is dynamic, never static. 

The third variable your clinic may not have discussed

Most fertility care focuses on two things: the quality of the embryo and the technical execution of the transfer.

Both matter. But fertilisation is not the same as stabilisation.

For pregnancy to continue, your body must actively support what comes next. The uterine lining must maintain blood flow. The immune environment must hold tolerance toward a genetically distinct embryo. Early placental structure must begin to form. Progesterone must be sustained.

All of this continues throughout the two-week wait.

When fertilisation occurs but pregnancy does not continue, the maternal physiological environment deserves the same attention as egg quality and sperm health.

The mother’s nutritional status is not simply about eating well. It determines whether the biological demands of early implantation can be met.

Egg quality. Sperm health. Maternal physiological environment. All three deserve equal preparation.

Implantation failure is not the same as embryo failure

Your clinic graded the embryo. It may have been chromosomally tested. On paper, it was your best available.

And it still did not result in pregnancy.

This is one of the hardest outcomes to sit with — because the expectation, spoken or unspoken, is that a good embryo makes pregnancy likely. When it does not follow, it is natural to question the embryo.

But embryo quality and uterine receptivity are separate variables. A chromosomally normal embryo transferring into an under-supported uterine environment may not implant. Not because the embryo failed. Because the environment was not ready to receive and sustain it.

The uterine environment is not fixed at the point of transfer. It is physiologically active throughout the entire two-week wait. It is shaped by blood flow, immune signalling, hormonal status, and inflammatory load — all of which are influenced by nutritional status.

This is the variable that is almost never discussed. It is also the variable most directly within your reach.

Explore the Implantation Support Meal Plan →

What is happening in your body during the two-week wait

There is a widespread assumption that once the transfer is done, nothing you do makes a difference.

The biology does not support this.

After embryo transfer, the embryo is establishing its first blood supply. Cells are dividing and beginning to differentiate into the specialised tissues that will form early placental structure. The maternal immune system is actively modulating — uterine natural killer cells are supporting vascular development when the immune environment is appropriately balanced. Progesterone is maintaining the lining. Inflammatory signals are either supporting or disrupting the process at every stage.

These are sustained biological processes. They continue for days. They respond to the nutritional environment throughout.

The nutritional demands of early implantation

After transfer, the embryo is establishing circulation, immune tolerance and early placenta structure.

These processes increase nutritional demand at a time when most women are focused entirely on waiting.

Omega-3 fatty acids are required for both endometrial blood flow and immune tolerance. Both remain active throughout the two-week wait. Both respond to whether adequate omega-3 status is present in the maternal body.

Folate, B12, and choline support the cell differentiation that begins almost immediately after implantation. From the earliest days, cells are dividing into blood cells, bone cells, and the specialised tissues that will form early placental structure. That process requires adequate methylation capacity. It does not wait for a positive test.

Zinc, magnesium, and B6 support progesterone production and regulate the cortisol response. Elevated cortisol directly suppresses progesterone. Progesterone is what holds the uterine lining in place after transfer. This is a hormonal mechanism with direct consequences — not a wellness concept.

Antioxidant status — from vitamin C, vitamin E, and polyphenol-rich foods — supports the vascular remodelling that determines whether early blood supply can establish reliably.

These are nutrients that are active in your body during the two weeks you are waiting. What you eat now directly shapes whether they are present in adequate amounts.

Your next transfer

The two weeks after your last transfer were some of the hardest you will have experienced. Watching the days pass. Trying to hold hope and manage fear at the same time. And then the result that brought you here.

What most women carry out of that experience is the question of whether they did enough. Whether there was something more they could have done.

The answer is that you did not have the information you needed. The maternal physiological environment — the third pillar — is the variable that is almost never discussed and almost never supported.

Your next transfer can be different. Not because the embryo will be better graded or the protocol more precise. Because the environment it transfers into will be actively prepared.

Your clinic will manage what your clinic manages. The nutritional environment during your two-week wait is yours to influence. Every meal measured and balanced around what your body needs during those fourteen days.

That is what changes between this transfer and the last one.

Every meal in the Now Baby Implantation Support Meal Plan is measured and balanced around the specific nutritional demands of the two-week wait — so that one thing, at least, is taken care of.

Explore the Implantation Support Meal Plan →

A chemical pregnancy after IVF means implantation began but did not hold.

Your embryo initiated contact with the endometrial surface.
Early attachment activity started.
Pregnancy hormone became detectable.
But the biological progression required to sustain early pregnancy did not stabilise in that cycle.

A positive test may have suggested that pregnancy was taking hold.
Then falling hormone levels or bleeding showed that implantation strength was not continuing to build.

Understanding what happened physiologically helps clarify what determines whether early pregnancy stabilises in the two-week wait after transfer.

What chemical pregnancy means after embryo transfer

Implantation is a developing biological sequence rather than a single event.

After transfer, your embryo begins interacting with the uterine lining at a cellular level.
Attachment activity initiates.
Hormonal signalling begins to support early pregnancy formation.
Energy demand increases as developmental activity progresses.

In a chemical pregnancy, this early interaction starts but does not deepen into stable attachment.

Your body recognises implantation activity.
Human chorionic gonadotropin rises briefly.
But the strengthening phase of implantation does not continue building.

This reflects implantation that initiated but did not stabilise.

Why implantation may begin but not strengthen

Successful early pregnancy depends on synchronisation between embryo development and maternal physiology.

Your embryo continues activating after transfer.
Cellular energy demand increases.
Developmental momentum must continue building.

At the same time, the uterine environment must remain responsive.

Endometrial circulation must support ongoing attachment.
Hormonal steadiness must continue after transfer.
Immune tolerance must adjust to early pregnancy signalling.
Wider metabolic balance influences how implantation consolidates.

If this coordination weakens, implantation activity may reduce before pregnancy becomes clinically established.

How early pregnancy hormone patterns reflect implantation strength

Human chorionic gonadotropin production begins as implantation develops.

In a chemical pregnancy, hormone production starts but remains limited.
Levels may rise for several days.
They may plateau.
They may then fall as implantation activity diminishes.

This reflects changes in implantation strength unfolding across days.

Your body is responding to shifts in early pregnancy development as they occur.

What this indicates about embryo developmental momentum

Embryo development continues after transfer.

Cellular organisation progresses.
Energy production intensifies.
Growth direction becomes clearer.

Some embryos initiate implantation but do not sustain developmental drive within that uterine environment.

This reflects the interaction between embryo physiology and maternal readiness in that cycle.

When synchronisation improves in a later transfer, implantation stability can change significantly.

The phase in which pregnancy direction is decided

A chemical pregnancy shows that implantation activity can begin but does not always progress into sustained early pregnancy.

What determines outcome in a subsequent transfer is not whether implantation starts, but how strongly it continues developing in the days that follow.

After embryo transfer, biological momentum must build quickly.
Attachment processes need to deepen.
Hormonal signalling must continue strengthening.
Circulatory responsiveness within the endometrium must support ongoing developmental demand.
Energy availability within the maternal environment influences whether implantation consolidates.

This post-transfer phase is short and biologically decisive.

Early pregnancy stability is shaped during the two-week wait while implantation activity is still evolving at a cellular level.
It is during this window that pregnancy either secures continued progression or begins to lose developmental strength.

Embarking on your next transfer may fill you with dread. By following the Now Baby implantation support plan from embryo transfer through the full two-week wait, your nutrition is precisely structured during the narrow biological window when early pregnancy is working to consolidate into sustained development.

It provides targeted nutritional structure during the exact phase in which implantation must continue building after transfer.
Supporting your physiology here can influence whether early pregnancy continues strengthening rather than losing momentum.

Follow the Now Baby implantation support plan from the day of embryo transfer to give early pregnancy the structured physiological support it requires during the two-week wait.

Moving forward after a chemical pregnancy

A chemical pregnancy means implantation started but did not secure ongoing development in that cycle.

Your embryo initiated biological interaction with your womb.
Early pregnancy signalling began.
But the progression required to maintain structural attachment and hormonal momentum did not continue.

The next transfer is a new implantation event.

Early implantation stability is determined in the days immediately after transfer, this is how your positive test occurs. Endometrial blood flow must remain responsive to support deepening attachment.
Hormone balance after transfer supports the continuation of implantation activity.
Cellular energy influences how securely early pregnancy consolidates.
Embryo-uterine communication depends on physiological conditions that sustain ongoing developmental momentum.

The two-week wait is the period in which pregnancy either stabilises or is lost. Supporting your physiology during this time helps implantation continue building so you can move forward toward meeting your baby.

In the days after transfer, your embryo begins hormonal signalling within your body.

Understanding hCG beta numbers helps you interpret how this early hormonal communication reflects how your pregnancy is progressing and how implantation stability is developing.

Human chorionic gonadotropin is released by trophoblast cells as implantation begins to secure within the uterine lining. This hormone supports progesterone function, sustains endometrial receptivity and strengthens the physiological conditions required for early pregnancy progression.

Each beta result reflects how strongly this hormonal signal is reaching your bloodstream at that stage of implantation development.

The first measurable signs that implantation is securing

Beta levels are measured as numerical values that reflect the amount of pregnancy hormone circulating in your blood at the time of testing.

Very early results can vary widely. Around nine to ten days after ovulation or embryo transfer, beta values may be as low as 20 to 50. By eleven to twelve days, levels are often higher, sometimes ranging from 50 to 150 or more depending on implantation timing.

These numbers are not targets. They reflect how far implantation has progressed and how efficiently hormonal signalling is entering circulation.

Many pregnancies that begin with lower early beta values continue progressing normally once implantation secures more deeply over the following days.

Rising hormone patterns as pregnancy physiology strengthens

Implantation unfolds across a dynamic physiological timeline. Hormonal output strengthens as vascular connection develops and embryonic growth continues.

For this reason, clinics often look for beta levels to increase by around 60 percent or more every forty-eight hours in early pregnancy. Many pregnancies show levels that approximately double within this timeframe, although normal variation exists.

Hormonal rise in early pregnancy reflects a process that is still stabilising, which means the internal conditions supporting implantation can continue influencing how strongly these patterns develop.

A steady upward trend suggests that implantation is securing and pregnancy physiology is becoming more established.

When hormonal change follows a different developmental pace

Hormone patterns do not always follow identical curves. Some embryos implant slightly later, which can result in lower initial values that then rise strongly once vascular integration improves.

In other situations, very high early numbers may reflect earlier implantation timing or multiple implantation activity rather than pregnancy strength alone.

The key physiological signal is forward hormonal movement supported by ongoing embryonic development.

The internal conditions that support hormonal signalling

Endometrial blood flow, glucose regulation, micronutrient sufficiency and inflammatory steadiness all influence how efficiently hormonal signalling strengthens during early pregnancy establishment.

When vascular adaptation and cellular energy availability are sustained, hormonal communication tends to build with greater continuity. Slower rises can occur while implantation consolidation is still progressing.

At this stage, implantation physiology is still actively strengthening, and the biological environment within your body remains highly relevant to how pregnancy stability continues to build.

Implantation support during this phase helps maintain the physical conditions your embryo relies on as hormonal signalling gathers strength. The implantation meal plan is designed to support metabolic stability and vascular readiness during this implantation stage..

By the time embryo transfer is being planned, your body is already shaping the conditions your embryo will meet.

Transfer timing determines when your embryo is placed into your uterus.
Your body determines what happens next.

The question is not simply fresh or frozen.
The question is what state your body is in when your embryo begins connecting with you.

How fresh and frozen transfer create different implantation starting points

Fresh transfer places the embryo into your uterus during the same cycle as egg retrieval, while your body is still recovering from stimulation.

Your hormone levels are still elevated.
Your body is still settling after the procedure.
Blood flow and immune activity have not fully settled at that point.

Your embryo begins connecting to you within that environment.

This means implantation is starting while your body is still adjusting.

Frozen transfer separates embryo transfer from the stimulation cycle, giving your body time to recover before implantation begins.

Hormone levels have time to settle.
Your uterus can be prepared more precisely.
Your body is in a more stable state at the point your embryo is transferred.

This creates a more controlled starting point for implantation.

How your body’s state affects implantation

Implantation is not automatic once an embryo is transferred.

It begins in the days that follow, as your embryo starts to attach and take hold within your uterus.

This is where the process that leads to your positive pregnancy test begins.

If your body is still fluctuating after stimulation, the process of implantation begins while your system is not yet fully settled.

If your body has stabilised, it begins within a more prepared environment.

This is where implantation either begins to build or struggles to establish.

You have already done everything required to reach this point.

What happens next is how implantation builds over the days that follow.

This period is often described as the two-week wait.

But it is not a passive phase.

It is when implantation is actively building towards your positive pregnancy test.

Implantation builds across 5 distinct phases within your uterine lining over the days that follow transfer, from initial attachment through early blood supply, placenta development and immune adaptation.

Each phase places different nutritional demands on your body as implantation continues to establish.

Implantation is supported by the right nutrients at the right time.

Access The Implantation Support Plan Now

Progesterone support will form part of your transfer protocol.

It prepares your uterus so implantation can begin.

Once transfer has taken place, implantation continues over the following days as early pregnancy starts to establish.

Your body is actively responding throughout this time.

Progesterone remains part of that process.

Implantation continues beyond it.

When fresh transfer remains appropriate

Fresh transfer can work well when your body has responded in a controlled way to stimulation and has settled quickly after retrieval.

Hormone levels are not excessively elevated.
Recovery is smooth.
Your body is already in a stable state when transfer takes place.

In this situation, implantation can begin in an environment that is already prepared.

When frozen transfer becomes the better option

Frozen transfer is often used when your body needs more time to recover after stimulation.

Hormone levels may be higher.
Recovery may take longer.
Your system may not yet be fully settled at the time your embryo would otherwise be transferred.

Delaying transfer allows your body to return to a more stable state before implantation begins.

Whether your transfer is fresh or frozen, this is the point where everything comes together.

You have already done everything required to reach this stage.

What matters now is how implantation will build over the days that follow.

Your embryo will begin to take hold within your uterus.

This is where that process will build, step by step, towards your positive pregnancy test.

And how consistently your body is supported during that time will influence how successfully that process builds.

By the time you reach embryo transfer, the focus shifts from fertilisation outcomes to the moment your embryo is placed into your uterus. Transfer timing now influences how implantation begins and how early pregnancy stabilises in your body.

How embryo development differs between day 3 and day 5

At day 3, your embryo is at the cleavage stage. Cells are dividing, but implantation structures have not yet formed.

By day 5, your embryo has developed into a blastocyst. Fluid expansion has occurred. The inner cell mass and trophectoderm are now distinct. Early developmental direction toward fetal tissue and placenta is already established.

This stage difference affects how prepared your embryo is to initiate implantation signalling after transfer.

How transfer timing shapes the start of implantation

When a day-3 embryo is transferred, development must continue within your uterus before implantation dialogue can begin. Your body supports further cellular organisation, blastocyst formation and metabolic activation during the first post-transfer days.

With a day-5 blastocyst transfer, these early developmental steps have already occurred. Implantation signalling may begin sooner because structural readiness has been reached.

This difference changes how rapidly biological demand increases across the implantation window and how precisely physiological stability must be maintained.

Access the Implantation Meal Plan now

What research shows about success rates

Across many IVF programmes, day-5 blastocyst transfer is associated with higher implantation and clinical pregnancy rates per transfer than day-3 transfer. Embryos that reach blastocyst stage have demonstrated sustained developmental progression, which supports more confident selection at the point of transfer.

However, transfer timing interacts with embryo cohort size, developmental pace and previous treatment history. When embryo numbers are limited or progression is slower, earlier transfer may preserve overall opportunity by allowing the uterine environment to support continued development.

Implantation success therefore reflects biological timing combined with individual cycle dynamics rather than transfer day alone.

Genetic testing considerations

Pre-implantation genetic testing requires access to trophectoderm cells that are present once the embryo reaches blastocyst stage. For this reason, genetic testing is performed on day-5 or later embryos and is not available at the day-3 cleavage stage.

This factor can shape transfer planning when genetic screening forms part of your treatment pathway.

Synchronisation between embryo stage and endometrial receptivity

Implantation depends on precise alignment between embryonic signalling and the receptive phase of your endometrium. Hormonal steadiness, vascular responsiveness and immune tolerance mechanisms all contribute to this timing window.

A day-3 transfer requires sustained physiological stability while development continues internally.

A day-5 transfer requires immediate coordination between an already differentiated embryo and the uterine surface.

In both scenarios, implantation progresses through strengthening attachment signals, adaptive circulation patterns and rising metabolic demand.

As implantation advances after transfer, your embryo deepens biological communication with your body, expands vascular integration and moves toward sustained early pregnancy development.

What embryo grading explained means in IVF

Embryo grading explained helps you understand what AA, BB or 3BB actually mean on your IVF report.
These grades describe how the embryo looked in the laboratory — not whether pregnancy will establish after transfer.

Embryo grading is not a single universal system.
Different clinics use slightly different grading frameworks, but most are variations of the same underlying method for assessing blastocyst development.

The most commonly used system is the Gardner blastocyst grading system.

In this system, grading is made up of three parts:

The number (1–6) refers to the degree of blastocyst expansion.
This describes how far the embryo has developed at the time it is assessed.

1–2 → early blastocyst (limited expansion)
3 → full blastocyst
4 → expanded blastocyst
5 → hatching blastocyst
6 → fully hatched blastocyst

Higher numbers indicate more advanced development at that moment in time.

The first letter (A–C) refers to the inner cell mass (ICM).
This group of cells later forms the fetus.

A → tightly packed, clearly defined cells
B → looser grouping, moderate organisation
C → fewer cells, less defined structure

The second letter (A–C) refers to the trophectoderm (TE).
These outer cells contribute to the placenta and are involved in implantation.

A → many cells forming a cohesive layer
B → fewer cells, less organised
C → sparse or irregular distribution

A grading such as 4AA therefore describes an expanded blastocyst with strong fetal and placental cell organisation.
A 3BB indicates a slightly earlier stage with moderate cellular structure.
A 5BC reflects a more advanced stage of expansion but with less cohesive cellular appearance.

Some clinics simplify this system into “good / fair / poor” categories or group embryos into top / average / low quality.
Others may report only the expansion stage or use modified lettering systems.

Day-3 embryo grading: cell number, symmetry and fragmentation

In earlier-stage embryos (commonly assessed around day 3), grading focuses on how the embryo is dividing.

Cell number reflects how many cells are present at that stage.
Embryos that are dividing in a coordinated way typically reach a predictable cell number by day 3, while slower or faster division can indicate variation in developmental timing.

Symmetry of division refers to how evenly those cells are sized.
When cells are of similar size, this suggests coordinated early development. Greater variation in cell size can indicate that division has occurred less synchronously at that stage.

Fragmentation describes small fragments of cellular material that appear between the cells.
These fragments are not functioning cells and are thought to result from uneven division or cellular stress during early development.

Lower levels of fragmentation are generally associated with more organised development, while higher levels may reflect reduced cellular cohesion at that point in time.
Fragmentation is usually described as a percentage of the embryo’s overall structure.

These features are considered together to give an overall impression of how early development is progressing, rather than being interpreted in isolation.

These may be described based on:

• number of cells
• symmetry of division
• degree of fragmentation

For example, an 8-cell embryo with minimal fragmentation is typically considered to be developing in a coordinated way at that stage.

Although the terminology can vary, all grading systems are attempting to describe the same thing:
how the embryo looks at a specific point in development.

What embryo grading is designed to estimate

Embryo grading describes appearance in the laboratory. Implantation determines what happens next.

Embryo grading is therefore a visual classification system, not a functional test.
It does not measure implantation directly or determine whether pregnancy will establish after transfer.
It provides a structured way to compare developmental appearance within a given cohort of embryos.

Understanding the grading language allows you to interpret your clinic report more clearly, particularly when multiple embryos are available and selection decisions are being made.

Why embryo grading cannot predict implantation with certainty

Although embryo grading describes how development appeared in the laboratory, the biological processes through which pregnancy begins to establish are part of the wider physiology of embryo implantation.

When a highly graded embryo still does not result in pregnancy

You may have been told your embryo was “excellent” or “top quality,” and the expectation — spoken or unspoken — was that pregnancy was now highly likely. When implantation does not follow, it can feel as though something unexpected or unusual has occurred.

From a physiological perspective, embryo grading reflects how the embryo appeared at a specific point in laboratory development. It does not determine how implantation will unfold once transfer takes place within the uterine environment. Even a well-graded blastocyst must still transition successfully from laboratory conditions to the dynamic maternal setting in which early pregnancy begins. A reassuring grading report can therefore create the impression that outcome is predictable, when in reality embryo grade indicates likelihood rather than guarantee.

Embryo grade is best understood as one element within a wider fertility picture — one that still includes maternal physiological responsiveness after transfer has taken place. Each transfer represents a time-limited biological opportunity for implantation to begin. The period that follows transfer is therefore clinically meaningful, as implantation is actively unfolding during this phase and conditions within the uterine environment continue to influence whether early pregnancy stabilises.

Embryo grading is useful for estimating the chance that pregnancy will start after transfer. It is less reliable for predicting whether that pregnancy will progress all the way to live birth.

What embryo grading is actually reflecting at the point of transfer

By the time an embryo is graded, it has already passed through several stages of early development under laboratory conditions. The grading description reflects how the embryo’s cells are organised, how the blastocyst has expanded, and how clearly early structural layers can be distinguished. This provides a visual snapshot of developmental progress at a specific moment.

Grading is therefore an observational measure rather than a functional test.
It indicates how efficiently early cellular division and differentiation have progressed up to that stage, but it does not directly measure how implantation will establish after transfer. Implantation depends on a sequence of physiological interactions that occur within the uterine environment during a narrow receptive phase.

A fuller explanation of grading terminology and grading scales is outlined in our detailed embryo grading guide.
Clinically, this distinction matters because grading labels are often interpreted as predictions. In practice, grading is better understood as an indicator of developmental momentum — information that helps guide expectation while recognising that implantation success is influenced by physiological conditions that continue to evolve beyond the laboratory setting.

How expected pregnancy rates shift across embryo grades

After receiving a grading report, many patients try to translate that description into a clear expectation. The practical question becomes what that grading may mean in real terms, particularly when clinic statistics or percentage estimates are discussed.

Embryo grading reflects visible patterns of cellular organisation, expansion and structural coherence. Across large IVF populations, these characteristics are associated with differing implantation and live-birth trends. Higher-graded blastocysts tend, on average, to implant more readily and progress to ongoing pregnancy more often than embryos showing slower or less cohesive early development.

In individual treatment cycles, however, these trends translate into variation rather than certainty.
Implantation attempts can occur without progressing to a sustained pregnancy, particularly if physiological conditions during the early post-transfer phase are not consistently supportive. Grading therefore helps shape expectation but does not determine outcome.

Understanding this allows practical decisions to be grounded in physiology rather than in laboratory appearance alone. It also helps place each transfer within a broader treatment trajectory, where supporting implantation conditions during the post-transfer phase becomes a purposeful part of care rather than an optional extra.

Why embryo grading success statistics are expressed as likelihood rather than certainty

At this stage of IVF treatment, it is natural to look for a clear prediction based on embryo grade. A grading report can appear to offer certainty about whether a transfer will succeed. In practice, grading data are used to estimate probability rather than to define outcome.

Grading reflects developmental characteristics observed in vitro. These features correlate with implantation and live-birth patterns across large patient groups, but they do not determine how implantation will unfold within an individual cycle. Once transfer has taken place, outcome depends on how effectively early pregnancy begins to establish during the implantation window.

Because this process unfolds in real time, success statistics are expressed as likelihood.
Population outcomes provide context, yet each transfer represents a distinct physiological event. Recognising this offers more deliberate preparation in the days immediately after transfer, when lifestyle patterns can influence the consistency of implantation conditions.

Why lower-graded embryos can still lead to healthy live births

A lower embryo grade can immediately feel like a reduced chance of success.
When grading descriptions are associated with lower average success rates, confidence in the upcoming transfer may begin to shift before implantation has had the opportunity to unfold.

In clinical reality, outcomes do not always follow laboratory grading hierarchy.
Embryos that appear less advanced or less cohesive at assessment can still implant and progress to healthy pregnancies. Grading reflects developmental appearance at a specific moment rather than the full capacity of the embryo to continue developing after transfer.

Once transfer occurs, the key task becomes successful implantation within the uterine lining. This process can vary from cycle to cycle, and grading alone does not determine how securely early pregnancy will establish. A lower grading description therefore signals greater variability, not absence of live-birth potential.

At this point in treatment, practical focus often shifts toward how implantation conditions are supported while the embryo is attempting to establish within the uterine lining.
Embryo grade can help estimate the chance that pregnancy will begin, but it does not guarantee that implantation will stabilise or that a live birth will follow.

The phase immediately after transfer is therefore clinically significant. Supporting uterine environment while implantation is unfolding can help create more consistent conditions for early pregnancy to establish. Taking structured action during this stage can also clarify interpretation afterwards, reducing uncertainty about whether key physiological foundations were actively supported during the implantation window.

After fertilisation, implantation is the decisive biological phase in which pregnancy either begins to establish or does not progress.

Access the Implantation Meal Plan here.

What embryo grading success rates realistically help you decide before the next transfer

Embryo grading helps estimate the likelihood that implantation can begin after transfer.
It does not determine whether the uterine environment will sustain your embryo as it starts to establish.

This distinction is clinically important.
Grading reflects how the embryo developed in the laboratory, whereas implantation success depends on how effectively early pregnancy embeds and stabilises within the uterine environment during the implantation window.

Understanding this allows grading results to guide expectation without creating false certainty.
The practical focus then shifts toward how consistently implantation conditions will be supported while pregnancy is attempting to take hold.

In real treatment decisions, embryo grade is therefore considered alongside physiological readiness in the transfer cycle ahead.
Early pregnancy develops through a tightly timed sequence of vascular adaptation, immune tolerance and metabolic regulation.
When these processes are supported consistently during the days following transfer, implantation is more likely to stabilise.

Supporting implantation during the two-week wait

After transfer, implantation continues to unfold as an active biological process rather than a single event.
The consistency of the uterine environment during this phase can influence whether early pregnancy strengthens or fails to progress.

Stable blood-sugar patterns, effective circulation and balanced inflammatory signalling help create conditions in which implantation can continue developing.

The Now Baby Implantation Meal Plan provides targeted nutritional structure during the two-week wait, helping you support the physiological processes involved while early pregnancy is establishing.

.

I know you are excited and anxious to confirm your pregnancy and start planning for your future.

Right now the only question for you is when can I test after embryo transfer.

If you are approaching this wait after a previous failed transfer or pregnancy loss, the uncertainty can feel even more intense because you are carrying memory of how this stage unfolded before. After your embryo transfer, everything can feel very still on the outside — yet inside your body implantation activity is already beginning.

Implantation strengthens before pregnancy hormone levels become detectable

Implantation starts when your embryo begins attaching to the lining of your uterus. As this attachment strengthens, specialised cells on the outer layer begin producing the hormone hCG. This hormone is the earliest measurable signal that pregnancy is establishing.

hCG first rises in the bloodstream and only later becomes detectable in urine. Because of this, pregnancy tests cannot turn positive immediately after transfer.

A reliable result only appears once implantation has progressed far enough for hCG levels to rise beyond the detection threshold of the test. The exact timing of this process naturally varies from one transfer to another.

Embryo developmental stage influences when implantation signals appear

One important influence is the developmental stage of your embryo at transfer.

A Day-5 blastocyst has already reached a stage where implantation may begin relatively soon after transfer. In some cycles, early hormone production can begin within a few days, and a faint positive pregnancy test may appear from around five to seven days later.

A Day-3 embryo still needs time to continue developing before implantation begins. In these situations, measurable hCG often rises later — sometimes not until seven to ten days after transfer or beyond.

For this reason, clinics usually recommend waiting for the scheduled blood test. By this point, implantation has usually had enough time to stabilise, allowing hormone levels to rise in a way that gives a clearer indication of whether early pregnancy is progressing.

Early pregnancy test results often reflect biological timing rather than outcome

The period after embryo transfer can feel like suspended time. Testing very early often produces results that are difficult to interpret because implantation may still be in its earliest stages.

At this stage, attachment between your embryo and the uterine lining may still be developing, and early trophoblast signalling is only beginning to establish measurable hormone production.

A negative pregnancy test during these first days often reflects that hCG has not yet risen beyond the detection threshold of the test. Similarly, a faint or fluctuating positive result can occur when hormone levels are still close to this threshold while implantation continues to stabilise.

Differences in attachment timing, the pace at which early circulation develops, and natural variation in how quickly hormone levels rise all influence what becomes visible on a home pregnancy test. These early results therefore represent a snapshot within an unfolding biological process rather than a definitive indication of how the transfer will progress.

Implantation progression is shaped by the internal uterine environment

Although embryo stage affects when implantation begins, the internal environment of the uterus also plays an important role.

Endometrial blood supply, hormonal stability after transfer, and the wider metabolic and inflammatory state of the body can all influence how smoothly implantation develops.

These factors help determine how effectively your embryo can attach, establish early circulation and begin producing rising levels of hCG. This is why pregnancy test timelines can vary even when embryos are transferred on the same day or at the same developmental stage.

The testing window is also a phase where implantation is still stabilising

After embryo transfer, it is easy to become absorbed in watching for physical signs while waiting for pregnancy test results to become clearer.

During these early days, implantation is still working to secure stable attachment within the uterine lining.

Hormone signalling is only beginning to strengthen.
Early circulation to the developing implantation site is still becoming established.

At this stage, implantation stability depends heavily on regular glucose availability, adequate micronutrient supply and consistent uterine blood flow.

If these internal conditions fluctuate, implantation signalling can weaken before pregnancy hormone levels have risen enough to be clearly detected.

Providing structured nutritional preparation during this specific testing window helps support the physiological processes that allow implantation to consolidate more securely while early pregnancy is still establishing.

After fertilisation, implantation is the decisive biological phase in which pregnancy either begins to establish or does not progress.

Support implantation during this critical two-week window

Preimplantation genetic testing IVF identifies chromosomally normal embryos before transfer and is frequently offered as a significant additional cost within IVF packages — yet even a genetically screened embryo does not guarantee a live birth.

Understanding the different types of PGT used in IVF

Preimplantation genetic testing (PGT) is an umbrella term used during IVF to describe genetic analysis of embryos before transfer. There are three main forms used in clinical practice.

PGT-A (Preimplantation Genetic Testing for Aneuploidy)
Screens embryos for the correct number of chromosomes. It is most commonly offered in the context of advanced maternal age, recurrent miscarriage, or repeated IVF failure, and is typically positioned as a way to reduce the risk of transferring an embryo with chromosomal abnormalities.

PGT-M (Preimplantation Genetic Testing for Monogenic conditions)
Used when one or both parents carry a known single-gene disorder. It identifies embryos affected by that specific inherited condition before transfer.

PGT-SR (Preimplantation Genetic Testing for Structural Rearrangements)
Recommended when a parent carries a chromosomal structural rearrangement, such as a balanced translocation, which can increase the risk of miscarriage.

Here we focus specifically on PGT-A, as it is the form most frequently offered as an additional cost within IVF packages and most commonly associated with miscarriage prevention and embryo selection decisions.

Clinical indicators for PGT-A in IVF

PGT-A is typically recommended in the following clinical situations:

• Advanced maternal age
• Recurrent miscarriage with proven embryo aneuploidy
• Repeated implantation failure following IVF
• Previous IVF cycles resulting in embryos identified as aneuploid
• Severe male factor infertility
• A positive PGT-SR result

The stated aim in these contexts is to reduce the likelihood of transferring an embryo with chromosomal abnormalities and, in some cases, to shorten time to pregnancy by prioritising embryos identified as euploid.

The clinical rationale is clear: where chromosomal abnormalities have been identified, selecting embryos classified as euploid — meaning they have the expected number of chromosomes — may reduce the likelihood of transferring an embryo with chromosomal imbalance. But PGT-A does not improve the embryo you transfer. It narrows the field. Once a euploid embryo is selected, the responsibility for implantation and sustained pregnancy shifts entirely to the biology of that embryo and the body receiving it.

Peace of mind

For many couples, the decision to proceed with PGT-A is not driven by statistics alone. It is driven by the desire for reassurance. After miscarriage, failed transfers, or unexpected results, selecting an embryo labelled “normal” can feel like restoring a degree of control.

PGT-A can reduce the likelihood of transferring an embryo with chromosomal abnormalities. That clarity can bring relief. It is also often positioned as a way to prioritise embryos more likely to result in pregnancy, particularly in cycles where embryo numbers are limited or previous transfers have failed.

Yet chromosomal screening occurs after stimulation, egg collection and fertilisation have already taken place. It does not influence how many eggs are retrieved, how many fertilise, or how many develop to blastocyst. It selects from what has already been created.

Peace of mind may come from selection. The number and developmental potential of embryos still depend on what happens earlier in the cycle.

UK regulatory data summarised by the Human Fertilisation and Embryology Authority (HFEA) reports that PGT-A has not been shown in randomised trials to improve live birth rates for most patients undergoing IVF

Your embryos’ potential starts earlier

IVF is expensive, invasive and physically demanding. Each cycle involves weeks of injections, scans, procedures and emotional strain. By the time an embryo reaches the stage where PGT-A can be performed, stimulation, fertilisation and early development have already taken place.

The number of eggs collected is your starting number. Every stage after that is attrition. Some eggs are immature. Some do not fertilise. Some embryos stop developing before day five. By the time embryos are ready for testing, that number has dropped.

How steep that drop is depends on how the ovaries respond to stimulation, how effectively eggs mature, and the integrity of sperm at fertilisation. In cycles where sperm parameters are low, ICSI may be used to assist fertilisation. ICSI helps a sperm enter the egg. It does not change the biological quality of that sperm. Fertilisation can occur with ICSI, but embryo development still reflects the underlying health and integrity of both egg and sperm.

These are biological variables that can be supported during the cycle itself. They shape how many embryos reach testing and how strong those embryos are. PGT-A then selects from that group.

Live birth reflects the whole cycle

Selecting a euploid embryo addresses chromosomal number. It refines which embryo is transferred.

Live birth reflects everything that led up to that point — how eggs responded during stimulation, how they completed maturation, how sperm contributed at fertilisation, and how embryos developed in the days that followed. These stages determine both the number of embryos available for testing and their developmental capacity.

PGT-A sits within that sequence. It supports selection. The biology that follows — whether in a fresh cycle or a frozen transfer — still depends on the physiological terrain.

Wherever you are in your IVF pathway

PGT-A refines embryo selection. It sits within a wider biological process that continues beyond testing. Whether you are preparing for stimulation, awaiting results, or planning a frozen transfer, the physiology of the cycle remains active.

Egg maturation, sperm integrity, hormonal signalling and endometrial preparation are not fixed events. They continue to influence how embryos develop and how pregnancy progresses. There is room for action at each stage.

After successful fertilization, implantation is the phase that allows the pregnancy to continue.

Explore the Implantation Meal Plan

Fewer cycles. Better outcomes.

Now Baby IVF Preparation supports the biological stages that influence embryo number, developmental potential and endometrial readiness during stimulation.

By supporting how eggs mature, how sperm contributes at fertilisation, and how the uterine environment prepares for transfer, the cycle itself can become more aligned with the outcome you are working towards.

PGT-A refines embryo selection within the group created during stimulation.
Supporting the physiology of that cycle helps shape both the number of embryos available for testing and their developmental capacity.

When live birth is the goal — and where possible embryos preserved for the future — preparing the cycle that produces them can bring your investment into clearer alignment with that aim.

Embryo implantation is often described as the moment a fertilised egg attaches to the uterine lining.

But attachment alone does not determine whether a pregnancy continues.

An embryo can form.
Cell division can begin.
A pregnancy test can turn positive.
And yet, development can stop.

When this happens, the focus usually returns to egg quality or sperm health.

Those matter. But fertilisation is not the same as stabilisation.

For pregnancy to continue, several biological processes must unfold in sequence — and they must be supported within the maternal body.

What Embryo Implantation Actually Requires

Implantation is not a single event. It marks the beginning of a demanding phase of early development.

Once the embryo reaches the uterus, five processes determine whether progression continues.

All of this happens within the first days and weeks after conception — long before a scan, and often before a woman even knows she is pregnant.

Implanting Securely into the Uterine Lining

Implantation occurs during a short progesterone-dependent window in the mid-luteal phase — typically lasting three to five days, around six to ten days after ovulation.

During this time, the endometrial lining expresses specific adhesion molecules and signalling factors that allow the embryo to attach and begin embedding.

This window is not simply about timing. The lining must be structurally prepared, hormonally signalled and supported by adequate blood flow so that embedding can stabilise.

If the window is mistimed, or if the lining is not fully prepared, even a competent embryo may struggle to implant securely.

Establishing an Early Blood Supply

Once implantation begins, vascular development becomes central to whether pregnancy continues.

The embryo is dividing rapidly. Oxygen demand increases. Nutrients must be delivered efficiently to support continued growth and early placental formation.

This requires coordinated signalling between the embryo and the maternal circulation. New blood vessels must form and remodel so that circulation can establish quickly and reliably.

If this early vascular development is suboptimal — whether through reduced blood flow, oxidative stress or insufficient metabolic support — implantation may begin but struggle to stabilise.

Attachment is only the first step. Sustained circulation allows development to continue.

Regulating Gene Expression and Cellular Differentiation

From the earliest days after fertilisation, cells are dividing and specialising.

Differentiation into blood cells, bone cells and brain cells begins long before a scan confirms pregnancy. These changes accelerate during the first eight weeks after conception — often weeks before a loss is detected clinically.

Gene expression must be tightly regulated for this process to unfold properly. That regulation depends on adequate methylation capacity and micronutrient availability, including folate, vitamin B12 and choline.

When these regulatory processes are constrained, development may begin but struggle to progress.

Beginning Placental Formation

The outer cells of the embryo begin embedding into the lining and form the early placenta.

This structure is responsible for nutrient transfer, hormonal signalling and continued vascular development. Placental formation is not a late event. It begins almost immediately after implantation.

If early placental signalling is disrupted, progression becomes unstable. Attachment alone is not sufficient. Sustained placental development supports continued growth.

Modulating the Maternal Immune Response

Successful implantation also requires immune adaptation.

The maternal immune system must shift toward tolerance, recognising the embryo while still supporting vascular remodelling and placental embedding.

Uterine natural killer (NK) cells are normally present in the endometrial lining and play a role in blood vessel development during implantation. The question is not whether they exist, but whether immune signalling is balanced during this critical window.

If immune regulation is disrupted, implantation may initiate but fail to stabilise.

Why Embryo Implantation Fails

Embryo implantation fails when one or more of these processes cannot be sustained.

Fertilisation may occur. The embryo may divide normally. But if implantation timing is mistimed, circulation cannot establish, gene regulation is impaired, placental formation falters or immune adaptation is incomplete, progression may not continue.

Implantation failure is rarely random. It reflects a breakdown in one or more of these biological processes.

The Fertility Trifecta

Fertility success depends on three biological conditions aligning:

• A competent egg
• A competent sperm
• A maternal physiological environment capable of supporting implantation and early development

Egg and sperm create the genetic blueprint.

But implantation and early progression depend on whether the maternal body can sustain what follows.

When fertilisation occurs but pregnancy does not continue, the maternal physiological environment deserves the same attention as egg and sperm health.

The Mother’s Nutritional Status and Early Differentiation

Gernand et al Nat Rev Endocrinol. 2016 May; 12(5): 274–289

Adapted from Gernard et al., Nat Rev Endocrinol (2016), illustrating stage-specific developmental nutrient demands.

The mother’s nutritional status is not simply about “eating well.”

It determines whether the biological demands of early development can be met.

After fertilisation, cells begin dividing and differentiating into blood cells, bone cells, brain cells and the specialised tissues that will form every organ.

At the same time, the embryo must implant, establish blood supply, regulate immune tolerance and initiate placental formation.

Early development is metabolically demanding. These processes rely on adequate micronutrient availability.

Before implantation, gene regulation and rapid cellular division are already underway.
At implantation, immune signalling and vascular development become critical.
As placental formation begins, nutrient transfer and blood supply must establish efficiently.
Throughout the first eight weeks, differentiation into blood cells, bone cells and brain cells accelerates.

Each stage relies on specific micronutrients.

Folate, B12 and choline support DNA synthesis and gene regulation.
Zinc and copper contribute to vascular development and tissue formation.

Choline contributes to neural development and methylation processes.
Iron supports oxygen transport and early placental development.
Zinc is involved in cell division and tissue formation.
Vitamin D influences immune tolerance and implantation signalling.
Iodine supports thyroid-driven developmental regulation.
Coenzyme Q10 and antioxidant nutrients help buffer oxidative stress during this metabolically demanding phase.

These nutrients work together within the maternal system to support implantation, differentiation and placental development.

When these demands are not met, stabilisation becomes more difficult — even when fertilisation has occurred.

After successful fertilization, implantation is the phase that allows the pregnancy to continue.

Explore the Implantation Meal Plan

Clinical Relevance

These biological processes become most visible when pregnancy does not progress.

The mechanisms that determine continuation are active within the first eight weeks of development — often weeks before a loss is identified clinically.

Implantation After IVF and Natural Conception

The biological requirements for implantation are the same in IVF and natural conception.

In IVF, embryo transfer places the embryo within the uterus, but implantation still depends on vascular signalling, immune tolerance and metabolic readiness within the maternal system.

In natural conception, fertilisation occurs before the embryo reaches the uterus. By implantation, cellular division and gene regulation are already underway.

In both scenarios, embryo implantation succeeds when embryo competence and maternal physiological capacity align.

Chemical Pregnancy

A chemical pregnancy usually reflects implantation that began but did not stabilise.

The embryo attaches. hCG production starts. A test becomes positive. But as cellular demand increases, the biological requirements of implantation intensify.

Circulation must establish. Placental signalling must strengthen. Gene regulation and differentiation accelerate.

If vascular development, immune adaptation or metabolic support cannot sustain this rapid progression, hormone levels fall and the pregnancy does not continue.

In many cases, the loss occurs within the first few weeks — often before a scan would detect a gestational sac.

The underlying processes that determine continuation were active long before the loss became visible.

Early Miscarriage

Most early miscarriages occur within the first eight weeks of development, even though they are often identified later at a 10–12 week scan.

By this stage, differentiation into blood cells, bone cells and brain cells is already underway. Placental development is accelerating. Oxygen demand is rising.

If the maternal system cannot sustain vascular development, immune tolerance and nutrient transfer at this pace, progression may stop.

This does not mean every miscarriage is preventable, nor that a single cause explains every loss.

But it does mean that implantation and early development depend on sustained physiological support — not a single moment of attachment.

Closing the Trifecta

When fertilisation occurs but pregnancy does not continue, the explanation does not always lie in egg quality or sperm competence alone.

Implantation depends on secure attachment, sustained circulation, regulated gene expression, placental development and immune adaptation within the maternal body.

If fertilisation is occurring but progression is not stabilising, these processes deserve to be examined together — not in isolation.

A fertility consultation allows egg health, sperm health and maternal physiological capacity to be reviewed as a connected system, so that implantation is supported deliberately rather than left to chance.

Read more about egg quality and sperm health

Egg Quality: How Follicle Health Shapes Development | Now Baby

Spermatogenesis: From Stem Cell to Sperm Formation and Packaging